Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data

Andrew R. Willan, Andrew H. Briggs, Jeffrey S Hoch

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

The current interest in undertaking cost-effectiveness analyses alongside clinical trials has lead to the increasing availability of patient-level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost-effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost-effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub-group analysis. This more general method can be used in either an incremental cost-effectiveness or an incremental net-benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression.

Original languageEnglish (US)
Pages (from-to)461-475
Number of pages15
JournalHealth Economics
Volume13
Issue number5
DOIs
StatePublished - May 2004
Externally publishedYes

Fingerprint

Cost-Benefit Analysis
regression
costs
Least-Squares Analysis
Cost-effectiveness
Regression method
Covariate adjustment
Clinical Trials
efficiency
Cost-effectiveness analysis
Costs
Group
Seemingly unrelated regression
Clinical trials
Ordinary least squares
Incremental
Factors
Efficiency gains
Incremental cost

Keywords

  • Clinical trials
  • Cost-effectiveness analysis
  • Covariate adjustment
  • Regression

ASJC Scopus subject areas

  • Nursing(all)
  • Economics and Econometrics
  • Health(social science)
  • Health Professions(all)

Cite this

Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. / Willan, Andrew R.; Briggs, Andrew H.; Hoch, Jeffrey S.

In: Health Economics, Vol. 13, No. 5, 05.2004, p. 461-475.

Research output: Contribution to journalArticle

@article{40b085bcee484dcb83fcbd5823ae1387,
title = "Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data",
abstract = "The current interest in undertaking cost-effectiveness analyses alongside clinical trials has lead to the increasing availability of patient-level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost-effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost-effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub-group analysis. This more general method can be used in either an incremental cost-effectiveness or an incremental net-benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression.",
keywords = "Clinical trials, Cost-effectiveness analysis, Covariate adjustment, Regression",
author = "Willan, {Andrew R.} and Briggs, {Andrew H.} and Hoch, {Jeffrey S}",
year = "2004",
month = "5",
doi = "10.1002/hec.843",
language = "English (US)",
volume = "13",
pages = "461--475",
journal = "Health Economics (United Kingdom)",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data

AU - Willan, Andrew R.

AU - Briggs, Andrew H.

AU - Hoch, Jeffrey S

PY - 2004/5

Y1 - 2004/5

N2 - The current interest in undertaking cost-effectiveness analyses alongside clinical trials has lead to the increasing availability of patient-level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost-effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost-effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub-group analysis. This more general method can be used in either an incremental cost-effectiveness or an incremental net-benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression.

AB - The current interest in undertaking cost-effectiveness analyses alongside clinical trials has lead to the increasing availability of patient-level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost-effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost-effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub-group analysis. This more general method can be used in either an incremental cost-effectiveness or an incremental net-benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression.

KW - Clinical trials

KW - Cost-effectiveness analysis

KW - Covariate adjustment

KW - Regression

UR - http://www.scopus.com/inward/record.url?scp=2442686638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442686638&partnerID=8YFLogxK

U2 - 10.1002/hec.843

DO - 10.1002/hec.843

M3 - Article

C2 - 15127426

AN - SCOPUS:2442686638

VL - 13

SP - 461

EP - 475

JO - Health Economics (United Kingdom)

JF - Health Economics (United Kingdom)

SN - 1057-9230

IS - 5

ER -